Delivery Order SPE2DB22D2206-SPE2DB25FKD32
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections valued at $7,255.25. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 14, 2025, with performance taking place at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. The contract, valued at $7,255.25, carries a firm fixed price and is scheduled for completion by October 8, 2025. This competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TREMFYA 200 mg/2 mL pen injections valued at $7,255.25. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. This...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $8,341.55 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TREMFYA 100 MG/ML pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 9, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections on September 12, 2025, with a ceiling value of $7,255.25 and a firm fixed price structure. This is a non-set-aside competitive award, with performance to be completed by October 3, 2025, at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within a larger pharmaceutical supply relationship between the contractor...
- The Defense Logistics Agency awarded a $7,255.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections. This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 28, 2025, with completion targeted for September 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TREMFYA 200 mg/2 mL pens valued at $21,765.75 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,255.25 by the Defense Logistics Agency (DLA) on June 30, 2025, for the supply of TREMFYA 100 mg/ml, a pharmaceutical product for federal medical procurement. The contract is classified as a Delivery Order under a Firm Fixed Price arrangement with no set-aside designation, indicating competitive award to the prime contractor. Performance of this order is scheduled to be completed by July 1, 2025, with fulfillment services...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD32Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. The contract is firm fixed price with no set-aside designation and is scheduled for completion by October 20, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This award is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible contract vehicles designed to ensure reliable pharmaceutical supply chains for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/26/25 |